(S (NP (NP (NNS Guidelines)) (PP (IN for) (NP (NP (DT the) (NN management)) (PP (IN of) (NP (NP (JJ atherosclerotic) (JJ cardiovascular) (NN disease)) (PRN (-LRB- -LRB-) (NP (NNP ASCVD)) (-RRB- -RRB-))))))) (VP (VBP recommend) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN risk) (NN stratification) (NNS models))) (S (VP (TO to) (VP (VB identify) (NP (NP (NNS patients)) (ADJP (RBS most) (JJ likely) (S (VP (TO to) (VP (VB benefit) (PP (IN from) (NP (UCP (NN cholesterol-lowering) (CC and) (JJ other)) (NNS therapies))))))))))))) (. .))
(S (NP (DT These) (NNS models)) (VP (VBP have) (NP (NP (NP (JJ differential) (NN performance)) (PP (IN across) (NP (NN race) (CC and) (NN gender) (NNS groups)))) (PP (IN with) (NP (NP (JJ inconsistent) (NN behavior)) (PP (IN across) (NP (NNS studies)))))) (, ,) (S (ADVP (RB potentially)) (VP (VBG resulting) (PP (IN in) (NP (NP (DT an) (JJ inequitable) (NN distribution)) (PP (IN of) (NP (JJ beneficial) (NN therapy)))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN work))) (, ,) (NP (PRP we)) (VP (VBP leverage) (NP (NP (JJ adversarial) (NN learning)) (CC and) (NP (NP (DT a) (JJ large) (JJ observational) (NN cohort)) (VP (VBD extracted) (PP (IN from) (NP (NP (JJ electronic) (NN health) (NNS records)) (PRN (-LRB- -LRB-) (NP (NNP EHRs)) (-RRB- -RRB-))))))) (S (VP (TO to) (VP (VB develop) (NP (NP (DT a) (`` ``) (JJ fair) ('' '') (NNP ASCVD) (NN risk) (NN prediction) (NN model)) (PP (IN with) (NP (NP (JJ reduced) (NN variability)) (PP (IN in) (NP (NN error) (NNS rates))) (PP (IN across) (NP (NNS groups)))))))))) (. .))
(S (NP (PRP We)) (VP (ADVP (RB empirically)) (VBP demonstrate) (SBAR (IN that) (S (NP (PRP$ our) (NN approach)) (VP (VBZ is) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG aligning) (NP (NP (DT the) (NN distribution)) (PP (IN of) (NP (NP (NN risk) (NNS predictions)) (VP (VBN conditioned) (PP (IN on) (NP (DT the) (NN outcome))))))) (PP (IN across) (NP (JJ several) (NNS groups))) (ADVP (RB simultaneously)) (PP (IN for) (NP (NP (NNS models)) (VP (VBN built) (PP (IN from) (NP (JJ high-dimensional) (NNP EHR) (NN data)))))))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBP discuss) (NP (NP (DT the) (NN relevance)) (PP (IN of) (NP (DT these) (NNS results))) (PP (IN in) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (NP (DT the) (JJ empirical) (NN trade-off)) (PP (IN between) (NP (NP (NN fairness)) (CC and) (NP (NN model) (NN performance)))))))))) (. .))
